• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有序贯淋巴细胞和髓细胞母细胞危象的晚期慢性髓性白血病的细胞遗传学差异图谱。

Differential cytogenetic profile in advanced chronic myeloid leukemia with sequential lymphoblastic and myeloblastic blast crisis.

作者信息

Calderón-Cabrera C, Montero I, Morales R M, Sánchez J, Carrillo E, Caballero-Velázquez T, Prats C, Bernal R, De Blas J M, Pérez-Simón J A

机构信息

UGC Hematología y Hemoterapia, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Sevilla, Spain.

UGC Genética, Reproducción y Medicina Fetal. Hospital Universitario Virgen del Rocío.

出版信息

Leuk Res Rep. 2013 Sep 21;2(2):79-81. doi: 10.1016/j.lrr.2013.08.001. eCollection 2013.

DOI:10.1016/j.lrr.2013.08.001
PMID:24371788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3850375/
Abstract

Frequency of additional chromosomal abnormalities in chronic myeloid leukemia (CML) is estimated to be 7% in chronic phase and increases to 40-70% in advanced disease. Progression of CML from chronic phase to accelerated phase or blast crisis is often associated with secondary chromosomal aberrations. We report an exceptional case of CML as debut in lymphoblastic blast crisis and a subsequent progression in myeloblastic blast crisis with rare cytogenetic abnormalities.

摘要

慢性髓性白血病(CML)中额外染色体异常的发生率在慢性期估计为7%,在疾病进展期则升至40%-70%。CML从慢性期进展为加速期或急变期通常与继发性染色体畸变有关。我们报告了1例罕见的首次表现为淋巴细胞母细胞急变期的CML病例,随后进展为粒细胞母细胞急变期,并伴有罕见的细胞遗传学异常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ab9/3850375/af52dbcdc03d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ab9/3850375/4de38872c72b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ab9/3850375/af52dbcdc03d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ab9/3850375/4de38872c72b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ab9/3850375/af52dbcdc03d/gr2.jpg

相似文献

1
Differential cytogenetic profile in advanced chronic myeloid leukemia with sequential lymphoblastic and myeloblastic blast crisis.伴有序贯淋巴细胞和髓细胞母细胞危象的晚期慢性髓性白血病的细胞遗传学差异图谱。
Leuk Res Rep. 2013 Sep 21;2(2):79-81. doi: 10.1016/j.lrr.2013.08.001. eCollection 2013.
2
[Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].[慢性粒细胞白血病急粒变与急淋变骨髓细胞形态学、免疫表型、细胞遗传学特征及预后的差异分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Jun;22(3):629-33. doi: 10.7534/j.issn.1009-2137.2014.03.010.
3
[Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].STI571治疗慢性髓性白血病患者的临床疗效及副作用
Ai Zheng. 2004 Apr;23(4):421-5.
4
Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.混合表型(T/B/髓系)髓外原始细胞危象作为慢性髓性白血病的初始表现。
Exp Mol Pathol. 2018 Apr;104(2):130-133. doi: 10.1016/j.yexmp.2018.02.005. Epub 2018 Mar 1.
5
U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.美国食品药品监督管理局药品批准总结:甲磺酸伊马替尼(STI571;格列卫)片剂从加速批准转为完全批准。
Clin Cancer Res. 2005 Jan 1;11(1):12-9.
6
Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression.费城染色体阳性的急性淋巴细胞白血病和慢性粒细胞白血病中的其他克隆异常在诊断时表现出不同的细胞遗传学模式,并且在疾病进展时遵循不同的途径。
Cancer Genet Cytogenet. 2005 Feb;157(1):53-61. doi: 10.1016/j.cancergencyto.2004.06.011.
7
[The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia].[慢性髓性白血病急变期的形态学、免疫表型及细胞遗传学特征研究]
Zhonghua Nei Ke Za Zhi. 2002 Oct;41(10):685-7.
8
Transformation of Chronic Myeloid Leukemia to Acute Biphenotypic Leukemia.慢性髓系白血病转化为急性双表型白血病。
J Med Cases. 2020 Aug;11(8):239-242. doi: 10.14740/jmc3511. Epub 2020 Jul 21.
9
Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.一名慢性粒细胞白血病急变期患者中BCR-ABL的扩增及t(3;21)
Cancer Genet Cytogenet. 2008 Jan 1;180(1):60-4. doi: 10.1016/j.cancergencyto.2007.09.014.
10
Precursor B cell lymphoid blast crisis of chronic myeloid leukemia with novel chromosomal abnormalities: A case report.慢性髓性白血病前体B细胞淋巴母细胞危象伴新型染色体异常:一例报告
Oncol Lett. 2018 Nov;16(5):6691-6696. doi: 10.3892/ol.2018.9497. Epub 2018 Sep 25.

本文引用的文献

1
Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way.伊马替尼耐药与慢性粒细胞白血病进展至急变期:体细胞高频突变助力其发展。
Cancer Cell. 2009 Sep 8;16(3):174-6. doi: 10.1016/j.ccr.2009.08.012.
2
Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia.慢性粒细胞白血病表现为双表型原始细胞危象,随后谱系转换为B淋巴细胞白血病。
Leuk Res. 2009 Nov;33(11):e195-8. doi: 10.1016/j.leukres.2009.04.026. Epub 2009 May 17.
3
Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy.
甲磺酸伊马替尼治疗慢性粒细胞白血病患者细胞遗传学克隆演变的预后意义
Blood. 2003 May 15;101(10):3794-800. doi: 10.1182/blood-2002-09-2790. Epub 2003 Jan 30.
4
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.慢性髓系白血病的细胞遗传学和分子遗传学演变
Acta Haematol. 2002;107(2):76-94. doi: 10.1159/000046636.
5
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.慢性粒细胞白血病对甲磺酸伊马替尼的血液学及细胞遗传学反应
N Engl J Med. 2002 Feb 28;346(9):645-52. doi: 10.1056/NEJMoa011573.
6
Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.一名处于髓系原始细胞危象的慢性髓性白血病患者在接受α干扰素治疗期间发生淋巴细胞原始细胞危象。
Int J Hematol. 2000 Dec;72(4):474-6.
7
[Chronic myelogenous leukemia characterized by successive lymphoid and myelomonocytic blast crises].
Rinsho Ketsueki. 1989 May;30(5):668-73.
8
Repeated blast crisis (BC) of changing morphology, immunologic phenotype and cytogenetics in chronic myeloid leukemia (CML).慢性粒细胞白血病(CML)中形态学、免疫表型和细胞遗传学不断变化的反复急变期(BC)
Anticancer Res. 1989 Nov-Dec;9(6):1721-3.
9
Phenotypic and genotypic switch in Philadelphia-positive, BCR-positive blast crisis of chronic myeloid leukemia.慢性髓系白血病费城染色体阳性、BCR阳性急变期的表型和基因型转换
Eur J Haematol. 1992 Apr;48(4):187-91. doi: 10.1111/j.1600-0609.1992.tb01583.x.